Issue Date: November 13, 2006
Beckman Coulter will acquire Lumigen for $185 million in cash. The Southfield, Mich.-based Lumigen develops and sells detection chemistries for high-sensitivity testing in clinical diagnostics and life sciences research. Lumigen had revenues of $33 million in 2005; about 40% of these came from sales of chemiluminescent substrates to Beckman Coulter for use in its Access family of immunoassay systems.
(1) Varian's new 320-MS quadrupole mass spectrometer is available either as a triple . . .
You Do Not Have Access to C&EN Protected Content.
Inside Instrumentation is written by
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society